4//SEC Filing
SCICLONE PHARMACEUTICALS INC 4
Accession 0000880771-17-000041
CIK 0000880771operating
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:30 PM ET
Size
8.0 KB
Accession
0000880771-17-000041
Insider Transaction Report
Form 4
Xie Lan
VP Finance China, CFO
Transactions
- Award
Restricted Stock Unit
2017-03-08+3,000→ 20,000 totalExp: 2027-03-08→ Common Stock (3,000 underlying) - Award
Non-Qualified Stock Option (right to buy)
2017-03-08+21,000→ 21,000 totalExercise: $9.65Exp: 2027-03-08→ Common Stock (21,000 underlying)
Footnotes (4)
- [F1]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F3]Vesting for such RSUs will occur 25% on March 8, 2018, 25% on March 8, 2019, 25% on March 8, 2020, and 25% on March 8, 2021, contingent upon the executive's continued employment.
- [F4]25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880771
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 5:30 PM ET
- Size
- 8.0 KB